Microbiology & toxicology testing services for the medical device and pharmaceutical industries.

Article

Sponsored Content

Wickham Laboratories Ltd is a trusted name in the pharmaceutical and medical device industries with over 50 years of experience in contract testing, research and consultancy.

At Wickham Laboratories, we maintain only the highest standard of quality at all stages while providing rapid turnaround for both routine testing and bespoke one-off projects.

 

Whether assisting a start-up company demonstrating proof of concept, or working with a global medical device manufacturer, our expert technicians recognise the importance of delivering an exceptional service by taking the time with every client to fully understand their individual requirements.

 

We are routinely inspected by the MHRA, FDA and Home Office, and offer the opportunity for clients to conduct audits on a regular basis.

 

Our services include:

  • Biocompatibility testing services; including cytotoxicity, sensitisation, implantation, systemic toxicity, intracutaneous reactivity and local irritation testing.

  • In vitro testing services; including bacterial endotoxin testing (LAL), cytotoxicity testing, the monocyte activation test (MAT), ELISA, BCA and Western blot.

  • Microbial identification; rapid identification (MALDI-ToF).

  • Quality control testing services including; bioburden, environmental monitoring, microbial limits (TAMC / TYMC and absence of specified pathogens), potable water and sterility testing.

  • Stability storage and testing.

  • Validation testing services; including antimicrobial / preservative efficacy testing, biological indicator enumeration, log reduction and microbial ingress challenges.

  • Toxicology testing services; including abnormal toxicity testing, potency bioassays and RPT.

Please contact +44 (0)1329 226600 for further information regarding our services.

 

Contact Details:

Company name: Wickham Laboratories Ltd
Website: www.wickhamlabs.co.uk
E-mail:mail@wickhamlabs.co.uk

Recent Videos
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Related Content